22 January 2016 - The independent Committee decided that a consultation on the draft recommendations was not needed for this appraisal, so the recommendations could go straight to a final appraisal determination. This happens when the Committee recommends a treatment in line with its licence.

For more details, go to: http://www.nice.org.uk/news/press-and-media/nice-draft-guidance-recommends-nivolumab-for-advanced-skin-cancer